ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

3.80
0.00 (0.00%)
26 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.80 3.60 4.00 3.80 3.80 3.80 205,010 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 3.19M -6.49M -0.0122 -3.11 20.27M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 3.80p. Over the last year, Eden Research shares have traded in a share price range of 3.50p to 7.25p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £20.27 million. Eden Research has a price to earnings ratio (PE ratio) of -3.11.

Eden Research Share Discussion Threads

Showing 18901 to 18916 of 19700 messages
Chat Pages: Latest  764  763  762  761  760  759  758  757  756  755  754  753  Older
DateSubjectAuthorDiscuss
16/9/2024
07:20
Timbo_Slice, you're no good even at lying.

You avidly wait for my every post, and scan it eagerly, no frantically, to find what I know and have found out. Clear as crystal.

Now eff orf! And continue to think Bonkers Subsonic is your friend. :D :D :D

neutralpov
15/9/2024
20:39
Neuts, can you please inject some humour otherwise you are going back on filter
money never sleeps
15/9/2024
20:01
But don't worry.

SUPERSONICO thinks you're great, and unlike him, you can spell!

(chortle)

neutralpov
15/9/2024
19:58
Timbo-of-many-fraudulent-IDs, you seem blissfully aware that you are going to jail for a long stretch for this elaborate boiler-room scam you have conducted here and on LSE, and that your "But everyone does it!" and "But I lost zillions myself!" defences not only completely fail but are actually counter-mitigative.

Timbo-of-many-fraudulent-IDs, you also seem blissfully aware that you lost the opportunity to listen to me and get out of this PoS when the share price was ALMOST FIVE TIMES HIGHER than it is now. Just think - if you bought back on the top to three point something pence, you would now have OVER FIVE TIMES more shares!

What does being THIS stooooooooooooooooooopid feel like, luzer?

ROTFLMAO @ sucker

P.S. Repeatedly logging out and re-logging in with your different aliases so as to uptick your own idiotic posts makes you a MEGA-LUZER. :D

neutralpov
14/9/2024
15:43
You seem blissfully unaware of your own mental state NPOV, as you hold no shares yet post repeatedly on a company you say is destined for zero pence. Thousands of posts and probably hundreds of hours.

What a waste of your time. Hah hah hah

kittybiscuits
14/9/2024
09:06
I'll book you both in for a double appointment
money never sleeps
14/9/2024
08:58
Oh, just shut up already.

And this company you keep desperately ramping, you know the one whose own directors don't buy its shares so you evidently think you are in a better position than they are to assess its prospects, has NOTHING WHATSOEVER TO DO WITH THE PANDEMIC (which was genuine) or COVID (which was/is real) or VACCINES (which, by and large, work) - all contrary to your assertions and implications.

Seek professional help (esp. mental health) somewhere else. It is not available here, loon.

:-)

Would I be correct in guessing being severely mentally-ill helps one be a LTH here?

;-)

neutralpov
14/9/2024
08:55
Just imagine the press when Science mag tells it's readers that Eden tech enhances the delivery capacity and effectiveness of Greenlight tech.
supersonico
13/9/2024
15:08
3LOGY – La soluzione intelligente e a basso impatto per controllare botrite, oidio e sclerotinia


...................

Humair Tariq

Follow
Eden Research plc’s bio-fungicide #Mevalone, based on #Sustaine™ technology and exempt from Maximum Residue Limits (#MRL), also marketed as #3LOGY in Italy by our partner Sipcam Italia. It is one of the leading products for controlling botrytis, downy mildew, and powdery mildew in grapes (wine and table varieties) and various horticultural crops grown in open fields and greenhouses.

supersonico
13/9/2024
12:23
We’ll find out soon enough. Investing is right, increased regions and greater product application uses will flatten that seasonal influence on Eden that will be a good thing. H2 has always historically been the stronger half.
kittybiscuits
13/9/2024
12:20
REITERATED RESTATED REAFFIRMED TARGET SHARE PRICE

EDEN RESEARCH plc

LSE:EDEN

ZERO PENCE (0.0000000000p)

neutralpov
13/9/2024
12:17
Alchemy 13 Sep '24 - 13:00 - 18502
"I lingered on slide 9 myself recently.
I’m still hoping H1 H1 yoy looks good."

That people this STOOOOOOOOOOOOOOOOOOOOOOOPID are (presumably) allowed to walk freely in society and even be permitted to use the internet is testament to the woeful state of the Mental Health Authorities in the UK....

lol

neutralpov
13/9/2024
12:00
I lingered on slide 9 myself recently.I'm still hoping H1 H1 yoy looks good.
alchemy
13/9/2024
11:12
TrickyWhen will you admit that you are a paid stooge of Eden.Your posts are wholly misleading as to Edens prospects.You have been pumping this share for years, yet the price keeps falling, alongside massive shareholder dilution. will you tell everyone that there is a hole in Edens bucket.
ravenna23
13/9/2024
10:55
I wouldn't rely on H1 this year too much. The Company has always said H2 is more significant. In my opinion, two things will change that moving forward.

1) Ever increasing regulatory approvals and label extensions to even out geographical climate/seasons and the variability that will bring

2) The introduction of, initially, Ecovelex, followed by the insecticide. Bigger sales and not weather dependent as with Mevalone for Botrytis

What I will be interested in is, any current/forward commentary post the trading period to indicate where we are in regards to expected announcements in H2 as detailed on slide 9 of this years AGM presentation.

Finally, in the InvestorMeetCompany filmed live communication earlier this year, management did say that in their opinion, the shares are worth north of the 20p price target that has been presented by Cavendish. That is a 500% rise on where we are today. That has obviously not been picked up in a significant way, so a film that explores where that value is and details it so investors understand it properly and then ensuring that communication hits enough people, would be a welcome development.

investingisatrickygame
13/9/2024
10:19
Nothing has changed with Eden. It is a company solely run for the benefit of Directors, you have yourself stated that they cannot be fired, despite their appalling performance. The product is too expensive. There is no financial benefit to users unless they produce an incredibly premium product. Make a sale to Chateau D'yquem, then perhaps success. However Eden cannot sell product at all. I have said this multiple times but nobody listens. Distribution is tied up with Corteva. It is in their interest for Eden to fail, then they can pick up the IP for nothing.Dream on Tricky.
ravenna23
Chat Pages: Latest  764  763  762  761  760  759  758  757  756  755  754  753  Older

Your Recent History

Delayed Upgrade Clock